Clinical Trials In Ophthalmology: One Doctor’s Unique Perspective – Dr. Carlos Quezada Ruiz
In this episode, Dr. Carlos Quezada Ruiz describes the evolution and challenges of clinical trials from his unique perspective as an active retina specialist who also oversees modules of some of the world’s most impactful clinical trials in Ophthalmology in his role as Senior Medical Director at Genentech. Dr. Quezada Ruiz further highlights the importance of a patient-centric approach for everyone working in the field of Ophthalmology, including industry professionals, basic scientists, and clinicians.
About the guest:
CARLOS QUEZADA-RUIZ, M.D., F.A.S.R.S.
Senior Medical Director, Clinical Science Ophthalmology
Carlos Quezada-Ruiz, M.D. is a Senior Medical Director on Genentech’s Ophthalmology Clinical Science team and a practicing retina specialist in Monterrey, Mexico. Carlos’ current work focuses on the advancement of new and better therapies for patients afflicted with retinal diseases around the world, including leading the Port Delivery System with ranibizumab Clinical Science team and the development of the neovascular age related macular degeneration program of Roche and Genentech’s faricimab (formerly RG7716), both programs currently in Phase III clinical trials. In the past, Carlos also led Lucentis mCNV and PFS medical teams, gene therapy and machine learning projects.
Carlos is Retina Surgeon and a board-certified ophthalmologist by the ECFMG (Educational Commission for Foreign Medical Graduates), the International Council of Ophthalmology and the Mexican Council of Ophthalmology and specializes in the treatment of medical and surgical retinal diseases such as diabetic retinopathy, retinal vein occlusion, retinal detachment and AMD.
Carlos has authored several peer-reviewed publications and book chapters and served as a peer reviewer and editorial board member for Ophthalmology journals. He is a member of the Mexican Society of Ophthalmology, the Pan-American Association of Ophthalmology, the American Academy of Ophthalmology (AAO), the Association for Research in Vision and Ophthalmology (ARVO), the Mexican Retina Society and the American Society of Retina Specialists (ASRS). He was honored as the 2013 CONACYT fellow abroad, the Gillingham Pan-American Fellow and was granted the 2013 Leonard Ellen Ocular Pathology Fellowship award, received the ASRS Honor Award in 2016, the ASRS Senior Honor Award in 2019 and was named Fellow of the American Society of Retina Specialists in 2021.
Carlos received his medical degree from the Autonomous University of Coahuila and completed his residency in Ophthalmology and his Vitreoretinal Surgery Fellowship at the Instituto de Oftalmologia Fundacion “Conde de Valenciana” in Mexico City. He then completed an Ocular Pathology Research Fellowship at McGill University in Montreal, Canada and a research fellowship in retinal diseases and vitreoretinal surgery with the California Retina Consultants and Research Foundation in Santa Barbara, CA.